Abstract
Fractures resulting from osteoporosis are a major public health problem. Physicians should be aware of the chief risk factors for osteoporosis and refer appropriately for bone densitometry. Risk factors include female sex, increased age, previous fracture, family history of fracture, slender habitus, early menopause, treatment with drugs known to affect bone (e.g. glucocorticoids) and diseases known to affect bone (e.g. rheumatoid arthritis). The diagnosis of osteoporosis can be made if the bone density T-score is −2.5 or below. This information can be used with other risk factors to estimate the 10-year risk of osteoporotic fractures. Patients with the highest risk of fracture benefit from many licensed treatments. These can be given orally (alendronic acid, risedronate sodium, ibandronic acid, calcitriol, raloxifene, hormone replacement therapy), subcutaneously (parathyroid hormone, denosumab) or intravenously (ibandronic acid, zoledronic acid), usually with a calcium and vitamin D supplement; this usually results in an increase in bone mineral density and a reduction in fracture risk. Osteoporosis can be prevented by careful attention to exercise and diet.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
